eFFECTOR Therapeutics, Inc.
EFTR · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $16 | $15 | $5 | $15 |
| Short-Term Investments | $10 | $3 | $12 | $10 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | -$0 | -$0 |
| Other Curr. Assets | $1 | $1 | $2 | $1 |
| Total Curr. Assets | $26 | $20 | $19 | $26 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $1 | $1 |
| Total NC Assets | $1 | $1 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $27 | $21 | $20 | $27 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $1 | $1 |
| Short-Term Debt | $20 | $21 | $20 | $20 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $3 | $2 | $2 |
| Total Curr. Liab. | $26 | $26 | $24 | $24 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $1 | $1 |
| Total NC Liab. | $1 | $1 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $26 | $26 | $24 | $24 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$188 | -$179 | -$170 | -$162 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $189 | $174 | $166 | $165 |
| Total Equity | $1 | -$6 | -$4 | $3 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $27 | $21 | $20 | $27 |
| Net Debt | $5 | $6 | $15 | $6 |